SleepRes announced today that it received FDA 510(k) clearance for its Kricket PAP device for treating obstructive sleep ...
GlobalData on MSN
FDA clears SleepRes’ Kricket PAP device for obstructive sleep apnoea
The FDA has granted 510(k) clearance to SleepRes’ KPAP-powered Kricket PAP device for the treatment of obstructive sleep ...
KPAP™ sleep therapy platform is designed to enable a more comfortable, adaptive, and patient-centered alternative to ...
Many are familiar with CPAP machines to treat sleep apnea, but fewer realize an oral appliance is an effective alternative. So how do you know if you’re a good candidate?
Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the NetherlandsFirst Genio implants successfully performed at OLVG West and ...
A class action lawsuit was filed against Inspire Medical Systems ($INSP) on November 6, 2025. Plaintiffs in the federal ...
Discusses Strategic Business Model Pivot and Transition in Sleep Apnea Treatment Approach December 16, 2025 11:00 ...
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes.
AMG Frontier Small Cap Growth Fund underperformed in Q3 2025. Click here to discover key detractors and top contributors.
TipRanks on MSN
Nyxoah launches Genio therapy in Netherlands and closes first €22.5 million tranche of convertible notes
Nyxoah ( ($NYXH) ) has issued an update. On December 17, 2025, Nyxoah announced the commercial launch of its Genio hypoglossal neurostimulation ...
PITTSBURGH, Dec. 18, 2025 /PRNewswire/ — Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced four recent regulatory milestones spanning across all stages of its global pipeline: ...
Southern California Pulmonary and Sleep Disorders Medical Center (805-557-9930) announces the expansion of its treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results